Request Quote
Kingphar Medical Group

New's

28/8 2025

Medical Gauze Raw Material Selection Standards

Table of Contents

Introduction

The production of sterile gauze represents one of the most critical aspects of medical device manufacturing, requiring stringent environmental controls to ensure patient safety and regulatory compliance. As healthcare systems worldwide demand higher quality standards, manufacturers must adhere to comprehensive Good Manufacturing Practice (GMP) guidelines that govern every aspect of sterile production environments. This article examines the essential environmental requirements for sterile gauze production, utilizing Kingphar Medical as a practical case study to illustrate industry best practices.

GMP Cleanroom Classification Requirements

Understanding GMP Grades

The GMP clean air grades and classifications define the environment in which sterile drugs and biological products should be manufactured. Under the GMP requirements, the manufacturing of sterile medicinal products can be distinguished into 4 grades: Grade A, B, C & D. For sterile gauze production, these classifications establish specific environmental parameters that manufacturers must maintain throughout the production process.

Grade A Environment Requirements:

  • Maximum particle count: 3,520 particles ≥0.5μm per cubic meter
  • Microbial contamination limits: <1 CFU/m³
  • Critical for aseptic processing and filling operations
  • Continuous monitoring required during operations

Grade B Environment Requirements:

  • Background environment for Grade A operations
  • Maximum particle count: 3,520 particles ≥0.5μm per cubic meter (at rest)
  • 352,000 particles ≥0.5μm per cubic meter (in operation)
  • Microbial limits: <10 CFU/m³

Grade C Environment Requirements:

  • Maximum particle count: 352,000 particles ≥0.5μm per cubic meter (at rest)
  • 3,520,000 particles ≥0.5μm per cubic meter (in operation)
  • Microbial limits: <100 CFU/m³
  • Suitable for less critical manufacturing steps

Grade D Environment Requirements:

  • Maximum particle count: 3,520,000 particles ≥0.5μm per cubic meter (at rest)
  • Not specified for in-operation conditions
  • Microbial limits: <200 CFU/m³
  • Used for less critical preparation areas

Essential Environmental Control Systems

Air Filtration and Circulation

Effective air filtration systems form the backbone of sterile gauze production environments. High-Efficiency Particulate Air (HEPA) filters with 99.97% efficiency at 0.3 micrometers must be installed at the final stage of air supply systems. The air circulation rate should maintain 20-30 air changes per hour for Grade C areas and higher rates for more critical zones.

Temperature and Humidity Control

Maintaining precise temperature and humidity levels is crucial for sterile gauze production:

  • Temperature range: 18-22°C (64-72°F)
  • Relative humidity: 45-65%
  • Variation tolerance: ±2°C for temperature, ±5% for humidity

These parameters prevent microbial growth while ensuring optimal material properties during manufacturing processes.

Pressure Differentials

Proper pressure cascades prevent cross-contamination between different manufacturing zones:

  • Grade A areas: 12-15 Pa positive pressure relative to Grade B
  • Grade B areas: 10-12 Pa positive pressure relative to Grade C
  • Grade C areas: 10-12 Pa positive pressure relative to Grade D
  • Grade D areas: 10-12 Pa positive pressure relative to external environment

Surface and Material Requirements

In cleanrooms and critical zones, all exposed surfaces should be smooth, impervious and unbroken, to minimize the shedding or accumulation of particles or micro-organisms. This requirement extends to:

  • Wall surfaces: Non-shedding, easily cleanable materials such as stainless steel or validated coatings
  • Flooring: Seamless, chemical-resistant materials that can withstand repeated disinfection
  • Ceilings: Smooth, non-particulate generating surfaces with integrated lighting systems
  • Equipment surfaces: 316L stainless steel or equivalent materials with proper surface finishes

Case Study: Kingphar Medical Implementation

Company Profile and Capabilities

Kingphar Medical is a professional manufacturer of Surgical Dressing, Dental and Woundcare products with ISO 13485 & CE Certificate. Now our main products include Medical Gauze, Non-woven, Absorbent Cotton, Elastic Bandages and so on. All of our products are being exported to more than 70 nations and regions, especially in Europe and USA. With more than 500 staff members, we are equipped with various looms, folding machines, sewing machines, 50 sets of sterile package equipment and bandage machines, and pure oxygen roll-type-bleaching lines.

Manufacturing Facility Design

Detail is the key of success. We pay high attention to every key details when we build and configure our manufacturing facility, which was designed and controlled by professional medicine design office, to make sure our facility can safely provide the excellent circumstance for production.

Kingphar Medical’s approach to sterile gauze production demonstrates several key environmental control principles:

Specialized Equipment Integration: The company’s 50 sets of sterile package equipment represent a significant investment in maintaining sterile production environments. These systems are designed to operate within controlled atmospheres that meet GMP requirements.

Process-Specific Environmental Controls: The pure oxygen roll-type-bleaching lines require specialized environmental controls to manage both product quality and safety considerations, including:

  • Oxygen concentration monitoring systems
  • Fire suppression systems designed for oxygen-enriched environments
  • Temperature control systems to prevent thermal reactions

Scalable Production Capacity: With facilities capable of exporting to more than 70 countries, Kingphar Medical has implemented environmental control systems that can maintain consistent conditions across large-scale production operations.

Quality Control and Environmental Monitoring

Continuous Monitoring Systems

Effective sterile gauze production requires real-time monitoring of environmental parameters:

Particle Counting:

  • Automated particle counters positioned throughout production areas
  • Real-time data logging with alarm systems for excursion events
  • Regular calibration and maintenance schedules

Microbial Monitoring:

  • Active air sampling using viable particle counters
  • Surface sampling using contact plates and swabs
  • Personnel monitoring through finger dabs and garment testing

Environmental Parameter Monitoring:

  • Temperature and humidity sensors with data logging capabilities
  • Pressure differential monitors with visual and audible alarms
  • Airflow velocity measurements at critical locations

Validation and Qualification Protocols

Installation Qualification (IQ): Verification that environmental control systems are installed according to specifications and design requirements.

Operational Qualification (OQ): Testing that systems operate within predetermined parameters under various operational conditions.

Performance Qualification (PQ): Demonstration that environmental control systems consistently produce conditions suitable for sterile gauze production.

Personnel Requirements and Training

Gowning Procedures

Personnel entering sterile production areas must follow strict gowning procedures:

  • Grade D areas: Basic cleanroom garments, hair covers, and shoe covers
  • Grade C areas: Full body coverage with sterile gowns and gloves
  • Grade B areas: Sterile suits with integrated hoods and face masks
  • Grade A areas: Completely enclosed suits with independent air supply

Training and Qualification

Comprehensive training programs must address:

  • Aseptic techniques and contamination control principles
  • Environmental monitoring procedures and alarm response
  • Equipment operation and maintenance requirements
  • Emergency procedures and deviation handling

Regulatory Compliance and Standards

International Standards

Sterile gauze production must comply with multiple regulatory frameworks:

FDA Requirements:

  • 21 CFR Part 820 (Quality System Regulation)
  • 21 CFR Part 211 (Current Good Manufacturing Practice)

European Union Standards:

  • EU GMP Annex 1 (Manufacture of Sterile Medicinal Products)
  • ISO 13485 (Medical Devices Quality Management)

WHO Guidelines:

  • WHO Technical Report Series guidelines for sterile pharmaceutical products

Validation Documentation

Comprehensive documentation systems must include:

  • Environmental monitoring SOPs and protocols
  • Cleaning and disinfection procedures
  • Change control systems for environmental modifications
  • Annual product quality reviews including environmental data

Risk Management Approach

Hazard Analysis and Risk Assessment

Systematic evaluation of potential contamination sources:

  • Raw material contamination risks
  • Equipment-related contamination sources
  • Personnel-related contamination factors
  • Environmental system failures

Contamination Control Strategies

Preventive Measures:

  • Proper facility design and material selection
  • Comprehensive personnel training programs
  • Regular equipment maintenance and calibration
  • Environmental monitoring and trend analysis

Corrective Actions:

  • Investigation protocols for environmental excursions
  • Product hold and evaluation procedures
  • Root cause analysis methodologies
  • Continuous improvement processes

Future Trends and Technologies

Advanced Environmental Control Technologies

Isolator Technology: Self-contained systems providing enhanced contamination control for critical operations.

Rapid Microbiological Methods: Real-time microbial detection systems enabling immediate response to contamination events.

Smart Environmental Monitoring: Internet of Things (IoT) integration for predictive maintenance and automated control systems.

Sustainability Considerations

Energy Efficiency:

  • Variable frequency drives for HVAC systems
  • Heat recovery systems for air handling units
  • LED lighting systems with occupancy sensors

Waste Reduction:

  • Optimized gowning procedures to reduce disposable garment usage
  • Water recycling systems for cleaning operations
  • Packaging optimization to reduce material waste

Conclusion

The production of sterile gauze requires a comprehensive approach to environmental control that integrates advanced technology, rigorous procedures, and continuous monitoring. As demonstrated by Kingphar Medical’s implementation, successful sterile gauze manufacturing depends on careful attention to facility design, equipment selection, and personnel training. The company’s investment in 500 sets of sterile packaging equipment and specialized production lines illustrates the commitment required to maintain GMP-compliant production environments.

The evolving regulatory landscape and advancing technologies continue to raise the standards for sterile production environments. Manufacturers must remain vigilant in their approach to environmental control, embracing new technologies while maintaining strict adherence to established principles of contamination control. The success of companies like Kingphar Medical in exporting to over 70 countries demonstrates that rigorous environmental controls not only ensure product quality and patient safety but also provide competitive advantages in global markets.

Future developments in environmental control technology, including advanced monitoring systems and sustainable production practices, will continue to shape the sterile gauze production industry. Manufacturers who invest in comprehensive environmental control systems and maintain strict adherence to GMP requirements will be best positioned to meet the growing global demand for high-quality sterile medical products.